Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4848958
Max Phase: Preclinical
Molecular Formula: C51H80N16O11
Molecular Weight: 1093.30
Molecule Type: Unknown
Associated Items:
ID: ALA4848958
Max Phase: Preclinical
Molecular Formula: C51H80N16O11
Molecular Weight: 1093.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCNC(=N)NC(=O)NCCCCNC(=O)CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C51H80N16O11/c1-30(2)27-39(47(76)62-36(10-7-25-58-49(54)55)45(74)64-38(43(53)72)28-31-12-16-33(68)17-13-31)65-46(75)37-11-8-26-59-50(56)67-51(78)60-24-6-5-23-57-41(70)20-21-42(71)61-35(9-3-4-22-52)44(73)66-40(48(77)63-37)29-32-14-18-34(69)19-15-32/h12-19,30,35-40,68-69H,3-11,20-29,52H2,1-2H3,(H2,53,72)(H,57,70)(H,61,71)(H,62,76)(H,63,77)(H,64,74)(H,65,75)(H,66,73)(H4,54,55,58)(H4,56,59,60,67,78)/t35-,36-,37-,38-,39-,40-/m0/s1
Standard InChI Key: SNNXLQDLWSXFSU-UNHORJANSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1093.30 | Molecular Weight (Monoisotopic): 1092.6192 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):